<DOC>
	<DOCNO>NCT02697617</DOCNO>
	<brief_summary>Funding Source - FDA OOPD Pioglitazone currently use clinical practice treat diabetes study examine potential use low dose drug treatment polycystic kidney disease . The purpose study determine whether diabetes drug pioglitazone ( Actos ) safe effective treatment autosomal dominant polycystic kidney disease treat early stage . Pioglitazone approve FDA treatment diabetes . Pre-clinical model polycystic kidney disease show low dose treatment pioglitazone decrease growth cyst . The study also suggest effective pioglitazone dose polycystic kidney disease may lower use treat diabetes . The purpose study see pioglitazone might slow cyst disease human .</brief_summary>
	<brief_title>Use Low Dose Pioglitazone Treat Autosomal Dominant Polycystic Kidney Disease</brief_title>
	<detailed_description>Patients randomize placebo 15 mg pioglitazone 12 month , cross arm . Patients undergo MRI liver kidney MRspectroscopy lumbar spine ( choose ancillary study ) three time study . Assessments every 3 month include blood work , blood pressure , body water assessment .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Male female ADPKD patient age 1855 eGFR â‰¥ 50 ml/min/1.73 m2 GFR formula Normal liver enzyme ( ALT/AST ) fast blood glucose 70 and120 female patient , willingness use double contraception avoid pregnancy study able give inform consent In opinion investigator , high likelihood progressive kidney disease diabetes , define follow : fast blood sugar &gt; 130 time two , HgbA1C &gt; 7 , blood sugar lower medication , past diagnosis diabetes occur pregnancy uncontrolled hypertension , define systolic &gt; 150 , diastolic &gt; 90 despite attempt physician titrate medication history impair systolic function ( ejection fraction &lt; 50 % ) previous ECHO know ischemic cardiovascular disease finding suggestive kidney disease ADPKD systemic illness require immunosuppressive antiinflammatory agent congenital absence kidney history total nephrectomy history cyst reduction partial nephrectomy history renal cyst aspiration within previous year History bladder cancer , gross hematuria inability undergo MRI due implantable device foreign object preclude MRI active renal transplant allergy sensitivity component test material institutionalize currently pregnant plan become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>